InpharmD
Chris W. has worked in a variety of roles since 1997. Chris began their career as an Equity Options Trader and then moved on to become a Professional Bridge Player in 2001. In 2007, they took a job as a Trader at Jane Street. From 2019 to 2021, they were a Senior Strategist and Communications Director at Zoic Capital. In 2021, they became an Adviser to the CEO at InpharmD. In 2022, they took on multiple roles, including Partner at Blackwood Healthcare Breakthroughs, Strategic Advisor to the CEO at HDT Bio, and Special Adviser at Medify.
Chris W. attended Williams College from 1993 to 1997.
This person is not in any teams
This person is not in any offices
InpharmD
1 followers
InpharmD's goal is for healthcare providers to have better access to better health information, so they can make better decisions. They connect questions from healthcare providers to customized, evidence-based responses from a nationwide network of academic drug information centers, optimized with machine learning, via their website and mobile application.